Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Rockwell Medical is a drug manufacturers-specialty & generic business based in the US. Rockwell Medical shares (RMTI) are listed on the NASDAQ and all prices are listed in US Dollars. Rockwell Medical employs 300 staff and has a trailing 12-month revenue of around $68.8 million.
Finder Award
SoFi Invest
tastyworks
| Latest market close | $1.90 |
|---|---|
| 52-week range | $0.84 - $5.50 |
| 50-day moving average | $1.24 |
| 200-day moving average | $1.66 |
| Wall St. target price | $5.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.76 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.9 from 2023-01-26
| 1 week (2023-01-20) | -2.56% |
|---|---|
| 1 month (2022-12-27) | 91.92% |
| 3 months (2022-10-27) | 95.88% |
| 6 months (2022-07-27) | 39.71% |
| 1 year (2022-01-23) | N/A |
|---|---|
| 2 years (2021-01-27) | 47.29% |
| 3 years (2020-01-27) | 2.69 |
| 5 years (2018-01-26) | 5.61 |
| Revenue TTM | $68.8 million |
|---|---|
| Gross profit TTM | $-2,420,000 |
| Return on assets TTM | -25.66% |
| Return on equity TTM | -185.52% |
| Profit margin | -36.7% |
| Book value | $1.45 |
| Market capitalisation | $21.9 million |
TTM: trailing 12 months
We're not expecting Rockwell Medical to pay a dividend over the next 12 months.
Rockwell Medical's shares were split on a 1:11 basis on 12 May 2022. So if you had owned 11 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Rockwell Medical shares – just the quantity. However, indirectly, the new 1000% higher share price could have impacted the market appetite for Rockwell Medical shares which in turn could have impacted Rockwell Medical's share price.
Over the last 12 months, Rockwell Medical's shares have ranged in value from as little as $0.84 up to $5.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rockwell Medical's is 1.0363. This would suggest that Rockwell Medical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Rockwell Medical, Inc. , together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
